Last reviewed · How we verify
Clinical Significance of Supraclavicular Lymph Node Dissection for Breast Cancer
Breast cancer patients with ipsilateral supraclavicular lymph node metastasis are defined as Ⅲc stage (N3) according to the newly published 8th AJCC TNM staging system. No concret guide line was supported to such patients. It is still pending whether to exert supraclavicular lymph node dissection to breast cancer patients with ipsilateral supraclavicular lymph node metastasis. To evaluate the clinical significance and complication of supraclavicular lymph node dissection for breast cancer patients with ipsilateral supraclavicular lymph node metastasis, the investigators randomize patients into two groups, one group is supraclavicular lymph node dissection with radiotherapy group, the other group is radiotherapy group.
Details
| Lead sponsor | Xinhong Wu, PhD |
|---|---|
| Phase | NA |
| Status | COMPLETED |
| Enrolment | 180 |
| Start date | Wed Feb 27 2019 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Sat Jan 20 2024 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Breast Cancer Stage III
Interventions
- supraclavicular lymph node dissection
- supraclavicular area radiotherapy
Countries
China